← All trials
NCT04849273
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 2, 2021
- Primary completion
- Apr 30, 2025
- Completion date
- Aug 31, 2026
- First posted
- Apr 19, 2021
- Last posted
- Nov 22, 2021
- Enrollment
- 210
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Turning Point TherapeuticsLead sponsor
- Turning Point TherapeuticsStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.